These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 20851941

  • 21. Multiple myeloma: predictive value of Tc-99m MIBI scintigraphy and MRI in its diagnosis and therapy.
    Myslivecek M, Nekula J, Bacovsky J, Scudla V, Koranda P, Kaminek M.
    Nucl Med Rev Cent East Eur; 2008; 11(1):12-6. PubMed ID: 19173182
    [Abstract] [Full Text] [Related]

  • 22. Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myeloma.
    Ailawadhi S, Abdelhalim AN, Derby L, Mashtare TL, Miller KC, Wilding GE, Alberico RA, Gottlieb R, Klippenstein DL, Lee K, Chanan-Khan AA.
    Cancer; 2010 Jan 01; 116(1):84-92. PubMed ID: 19862816
    [Abstract] [Full Text] [Related]

  • 23. Analysis of the serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and different stages of multiple myeloma.
    Scudla V, Petrova P, Minarik J, Pika T, Bacovsky J.
    Neoplasma; 2011 Jan 01; 58(6):499-506. PubMed ID: 21895403
    [Abstract] [Full Text] [Related]

  • 24. [Comparative study of 2 prognostic classification systems for myeloma and examination of the correlation between initial bone marrow plasmacytosis and prognosis. A propos of a homogeneous population of 50 patients followed from diagnosis to death].
    Pesce A, Cassuto JP, Grisot C, Gratecos N, Bayle J, Viot G, Dujardin P.
    Nouv Rev Fr Hematol (1978); 1983 Jan 01; 25(5):311-7. PubMed ID: 6657481
    [Abstract] [Full Text] [Related]

  • 25. [Prognostic analysis and assessment on the clinical staging systems of multiple myeloma--a report of 206 cases].
    Tao ZF, Fu WJ, Chen YB, Yuan ZG, Wang DX, Hou J.
    Ai Zheng; 2006 Apr 01; 25(4):461-4. PubMed ID: 16613681
    [Abstract] [Full Text] [Related]

  • 26. Analysis of chromosome 12p deletion in plasma cell dyscrasias.
    Jiang N, Qi C, Yu L, Ning Y, An G, Qiu L, Chang H.
    Leuk Res; 2012 Jan 01; 36(1):32-6. PubMed ID: 21982640
    [Abstract] [Full Text] [Related]

  • 27. International prognostic index (IPI)--a critical comparison with five multiple myeloma staging systems in the group of 270 patients treated by conventional chemotherapy.
    Scudla V, Zemanova M, Minarik J, Bacovsky J, Ordeltova M, Indrak K, Budikova M, Dusek L, Farbiakova V.
    Neoplasma; 2006 Jan 01; 53(4):277-84. PubMed ID: 16830053
    [Abstract] [Full Text] [Related]

  • 28. Role of MRI for the diagnosis and prognosis of multiple myeloma.
    Baur-Melnyk A, Buhmann S, Dürr HR, Reiser M.
    Eur J Radiol; 2005 Jul 01; 55(1):56-63. PubMed ID: 15950101
    [Abstract] [Full Text] [Related]

  • 29. [Magnetic resonance tomography in plasmacytoma: ranking of various sequences in diffuse and focal infiltration patterns].
    Baur A, Stäbler A, Steinborn M, Schnarkowski P, Pistitsch C, Lamerz R, Bartl R, Reiser M.
    Rofo; 1998 Apr 01; 168(4):323-9. PubMed ID: 9589093
    [Abstract] [Full Text] [Related]

  • 30. Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates.
    Stäbler A, Baur A, Bartl R, Munker R, Lamerz R, Reiser MF.
    AJR Am J Roentgenol; 1996 Oct 01; 167(4):1029-36. PubMed ID: 8819407
    [Abstract] [Full Text] [Related]

  • 31. Imaging in multiple myeloma.
    Delorme S, Baur-Melnyk A.
    Eur J Radiol; 2009 Jun 01; 70(3):401-8. PubMed ID: 19272726
    [Abstract] [Full Text] [Related]

  • 32. Whole-body MRI versus whole-body MDCT for staging of multiple myeloma.
    Baur-Melnyk A, Buhmann S, Becker C, Schoenberg SO, Lang N, Bartl R, Reiser MF.
    AJR Am J Roentgenol; 2008 Apr 01; 190(4):1097-104. PubMed ID: 18356461
    [Abstract] [Full Text] [Related]

  • 33. Soluble syndecan-1 levels in different plasma cell dyscrasias and in different stages of multiple myeloma.
    Jánosi J, Sebestyén A, Mikala G, Németh J, Kiss Z, Vályi-Nagy I.
    Haematologica; 2004 Mar 01; 89(3):370-1. PubMed ID: 15020284
    [Abstract] [Full Text] [Related]

  • 34. International staging system for multiple myeloma.
    Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Bladé J, Boccadoro M, Child JA, Avet-Loiseau H, Kyle RA, Lahuerta JJ, Ludwig H, Morgan G, Powles R, Shimizu K, Shustik C, Sonneveld P, Tosi P, Turesson I, Westin J.
    J Clin Oncol; 2005 May 20; 23(15):3412-20. PubMed ID: 15809451
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. State-of-the-Art Imaging and Staging of Plasma Cell Dyscrasias.
    Amini B, Yellapragada S, Shah S, Rohren E, Vikram R.
    Radiol Clin North Am; 2016 May 20; 54(3):581-96. PubMed ID: 27153790
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma.
    Kaiser M, Mieth M, Liebisch P, Oberländer R, Rademacher J, Jakob C, Kleeberg L, Fleissner C, Braendle E, Peters M, Stover D, Sezer O, Heider U.
    Eur J Haematol; 2008 Jun 20; 80(6):490-4. PubMed ID: 18331598
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.